BusinessMetabolon Launches Meta UDx™ Test to Speed Diagnosis of Rare and Undiagnosed Diseases in Children and AdultsBy Nasdaq OMXFeb 28, 2018, 3:50 PM UTC
BusinessMetabolon Launches Meta IMD™ Test to Speed Diagnosis of Inherited Metabolic DisordersBy Nasdaq OMXSep 28, 2016, 2:05 PM UTC
BusinessBioMarin Receives Orphan Drug Designation From FDA for First AAV-Factor VIII Gene Therapy, BMN 270, for Patients With Hemophilia ABy Nasdaq OMXMar 1, 2016, 10:43 PM UTC
BusinessBioMarin Announces BioMarin RareConnections(TM) Rebranding and Consolidating BioMarin’s Comprehensive Support and Services for Eligible Rare Disease PatientsBy Nasdaq OMXFeb 29, 2016, 1:30 PM UTC
BusinessBioMarin Announces 21 Presentations at 12th Annual WORLDSymposium™ 2016 February 29-March 4 in San Diego, California: 6 Oral and 15 PosterBy Nasdaq OMXFeb 29, 2016, 1:25 PM UTC
